Cervical Length Pre-induction as a Tool to Predict Vaginal Birth
Sponsor
Saint Thomas Hospital, Panama (Other)
Overall Status
Completed
CT.gov ID
NCT02916082
Collaborator
(none)
200
1
9
22.2
Study Details
Study Description
Brief Summary
To evaluate the value of measuring cervical length as a predictor of vaginal birth after induction of labor with prostaglandins in pregnancies with 41 weeks of gestation.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
200 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Use of Cervical Length Previous to the Use of Prostaglandins as a Tool to Predict Vaginal Birth in Pregnancies With > 41 Weeks Gestation.
Study Start Date
:
Nov 1, 2015
Actual Primary Completion Date
:
Jun 1, 2016
Actual Study Completion Date
:
Aug 1, 2016
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Prolonged pregnancy Pregnancies with 41 weeks or more of gestation determined by a reliable last menstrual period or early fetal ultrasound. |
Procedure: Cervical length measurement
Vaginal ultrasound to measure cervical length previous to use of prostaglandins.
|
Outcome Measures
Primary Outcome Measures
- Vaginal Birth [72 hours]
Number of vaginal births obtained after a measure of cervical length below 2,5 cms.
Secondary Outcome Measures
- Induction to delivery time [72 hours]
Time (hours) between the application of a prostaglandin and termination of pregnancy (vaginal or cesarean).
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
41 weeks or more of gestational age
-
Cervical length measured by a FMF certified physician
Exclusion Criteria:
- Any condition that could interfere with a possible vaginal birth (previous cesarean section, hypertensive disorders of pregnancies).
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Saint Thomas H | Panama | Panama |
Sponsors and Collaborators
- Saint Thomas Hospital, Panama
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Osvaldo A. Reyes T.,
Coordinator of Research,
Saint Thomas Hospital, Panama
ClinicalTrials.gov Identifier:
NCT02916082
Other Study ID Numbers:
- 2015-288V2
First Posted:
Sep 27, 2016
Last Update Posted:
Sep 27, 2016
Last Verified:
Sep 1, 2016
Keywords provided by Osvaldo A. Reyes T.,
Coordinator of Research,
Saint Thomas Hospital, Panama
Additional relevant MeSH terms: